FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:1897-1904 December 24, 1998 Number 26 Next

	Full Text PDF Editorial by Steinbrook, R. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods In order to elucidate the medical care of patients with human immunodeficiency virus (HIV) infection in the United States, we randomly sampled HIV-infected adults receiving medical care in the contiguous United States at a facility other than a military, prison, or emergency department facility during the first two months of 1996. We interviewed 76 percent of 4042 patients selected from among the patients receiving care from 145 providers in 28 metropolitan areas and 51 providers in 25 rural areas.

Results During the first two months of 1996, an estimated 231,400 HIV-infected adults (95 percent confidence interval, 162,800 to 300,000) received care. Fifty-nine percent had the acquired immunodeficiency syndrome according to the case definition of the Centers for Disease Control and Prevention, and 91 percent had CD4+ cell counts of less than 500 per cubic millimeter. Eleven percent were 50 years of age or older, 23 percent were women, 33 percent were black, and 49 percent were men who had had sex with men. Forty-six percent had incomes of less than $10,000 per year, 68 percent had public health insurance or no insurance, and 30 percent received care at teaching institutions. The estimated annual direct expenditures for the care of the patients seen during the first two months of 1996 were $5.1 billion; the expenditures for the estimated 335,000 HIV-infected adults seen at least as often as every six months were $6.7 billion, which is about $20,000 per patient per year.

Conclusions In this national survey we found that most HIV-infected adults who were receiving medical care had advanced disease. The patient population was disproportionately male, black, and poor. Many Americans with diagnosed or undiagnosed HIV infection are not receiving medical care at least as often as every six months. The total cost of medical care for HIV-infected Americans accounts for less than 1 percent of all direct personal health expenditures in the United States.

Source Information

From RAND Health, Santa Monica, Calif. (S.A.B., S.H.B., N.D., A.A.L., J.W.S., S.C.M., M.F.S.); the Veterans Affairs San Diego Healthcare System, San Diego, Calif., and the University of California at San Diego, La Jolla (S.A.B.); the University of California at Los Angeles (A.A.L., M.F.S.); the National Opinion Research Center, Chicago (M.R.F., C.-A.E.); Baruch College, City University of New York, New York (M.R.F.); Project Hope, Bethesda, Md. (M.L.B.); and the Agency for Health Care Policy and Research, Rockville, Md. (D.L.). Other authors were Ronald M. Andersen, Ph.D., William E. Cunningham, M.D., M.P.H., Marvin Marcus, D.D.S., M.P.H., and Neil S. Wenger, M.D., University of California at Los Angeles; Leslie A. Athey, M.S., and Stephen M. Smith, M.A., National Opinion Research Center, Chicago; Eric G. Bing, M.D., Drew University, Los Angeles; Julie A. Brown, B.A., M. Audrey Burnham, Ph.D., Dana P. Goldman, Ph.D., David E. Kanouse, Ph.D., Joan W. Keesey, B.A., Daniel F. McCaffrey, Ph.D., Judith F. Perlman, M.A., and Mark A. Schuster, M.D., Ph.D., RAND Health, Santa Monica, Calif.; Paul D. Cleary, Ph.D., Harvard Medical School, Boston; John A. Fleishman, Ph.D., Agency for Health Care Policy and Research, Rockville, Md.; Ron D. Hays, Ph.D., RAND Health, Santa Monica, Calif., and the University of California at Los Angeles; J. Allan McCutchan, M.D., and Douglas Richman, M.D., University of California at San Diego, La Jolla.

Address reprint requests to Dr. Bozzette or Dr. Shapiro, HCSUS Office, RAND, 1700 Main St., Santa Monica, CA 90407-2138.

Full Text of this Article

This article has been cited by other articles:

• Hessamfar-Bonarek, M., Morlat, P., Salmon, D., Cacoub, P., May, T., Bonnet, F., Rosenthal, E., Costagliola, D., Lewden, C., Chene, G., the Mortalite 2000 & 2005 Study Groups, (2010). Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalite 2000 & 2005' Surveys (ANRS EN19). Int J Epidemiol 39: 135-146 [Abstract] [Full Text]  
• Sanders, G. D., Bayoumi, A. M., Holodniy, M., Owens, D. K. (2008). Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age. ANN INTERN MED 148: 889-903 [Abstract] [Full Text]  
• Torian, L. V., Wiewel, E. W., Liu, K.-L., Sackoff, J. E., Frieden, T. R. (2008). Risk Factors for Delayed Initiation of Medical Care After Diagnosis of Human Immunodeficiency Virus. Arch Intern Med 168: 1181-1187 [Abstract] [Full Text]  
• Ohl, M. E., Landon, B. E., Cleary, P. D., LeMaster, J. (2008). Medical Clinic Characteristics and Access to Behavioral Health Services for Persons With HIV. Psychiatr. Serv. 59: 400-407 [Abstract] [Full Text]  
• Rodriguez, H. P., Marsden, P. V., Landon, B. E., Wilson, I. B., Cleary, P. D. (2008). The Effect of Care Team Composition on the Quality of HIV Care. Med Care Res Rev 65: 88-113 [Abstract]  
• Nicastri, E., Leone, S., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., Vella, S., Narciso, P., Corpolongo, A., Andreoni, M. (2007). Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 60: 724-732 [Abstract] [Full Text]  
• Fremont, A. M., Young, A. S., Chinman, M., Pantoja, P., Morton, S., Koegel, P., Sullivan, G., Kanouse, D. (2007). Differences in HIV Care Between Patients With and Without Severe Mental Illness. Psychiatr. Serv. 58: 681-688 [Abstract] [Full Text]  
• Zingmond, D. S., Ettner, S. L., Cunningham, W. E. (2007). The Impact of Managed Care on Access to Highly Active Antiretroviral Therapy and on Outcomes among Medicaid Beneficiaries with AIDS. Med Care Res Rev 64: 66-82 [Abstract]  
• Reif, S., Geonnotti, K. L., Whetten, K. (2006). HIV Infection and AIDS in the Deep South. AJPH 96: 970-973 [Abstract] [Full Text]  
• Bogart, L. M., Collins, R. L., Kanouse, D. E., Cunningham, W., Beckman, R., Golinelli, D., Bird, C. E. (2006). Patterns and Correlates of Deliberate Abstinence Among Men and Women With HIV/AIDS. AJPH 96: 1078-1084 [Abstract] [Full Text]  
• Tien, P. C., Benson, C., Zolopa, A. R., Sidney, S., Osmond, D., Grunfeld, C., for the FRAM Study Investigators, (2006). The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM): Methods, Design, and Sample Characteristics. Am J Epidemiol 163: 860-869 [Abstract] [Full Text]  
• McGavern, D. B. (2006). Immunotherapeutic relief from persistent infections and amyloid disorders. Neurology 66: S59-S64 [Abstract] [Full Text]  
• FREED, J. R., MARCUS, M., FREED, B. A., DER-MARTIROSIAN, C., MAIDA, C. A., YOUNAI, F. S., YAMAMOTO, J. M., COULTER, I. D., SHAPIRO, M. F. (2005). Oral health findings for HIV-infected adult medical patients from the HIV Cost and Services Utilization Study. Journal of the American Dental Association 136: 1396-1405 [Abstract] [Full Text]  
• Nahin, R. L. (2005). Identifying and pursuing research priorities at the National Center for Complementary and Alternative Medicine. FASEB J. 19: 1209-1215 [Abstract] [Full Text]  
• Chou, R., Huffman, L. H., Fu, R., Smits, A. K., Korthuis, P. T. (2005). Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 143: 55-73 [Abstract] [Full Text]  
• Walensky, R. P., Weinstein, M. C., Smith, H. E., Freedberg, K. A., Paltiel, A. D. (2005). Optimal Allocation of Testing Dollars: The Example of HIV Counseling, Testing, and Referral. Med Decis Making 25: 321-329 [Abstract]  
• Ding, L., Landon, B. E., Wilson, I. B., Wong, M. D., Shapiro, M. F., Cleary, P. D. (2005). Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users. Arch Intern Med 165: 618-623 [Abstract] [Full Text]  
• Sanders, G. D., Bayoumi, A. M., Sundaram, V., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., Owens, D. K. (2005). Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. NEJM 352: 570-585 [Abstract] [Full Text]  
• Paltiel, A. D., Weinstein, M. C., Kimmel, A. D., Seage, G. R. III, Losina, E., Zhang, H., Freedberg, K. A., Walensky, R. P. (2005). Expanded Screening for HIV in the United States -- An Analysis of Cost-Effectiveness. NEJM 352: 586-595 [Abstract] [Full Text]  
• Young, A. S., Sullivan, G., Bogart, L. M., Koegel, P., Kanouse, D. E. (2005). Needs for Services Reported by Adults With Severe Mental Illness and HIV. Psychiatr. Serv. 56: 99-101 [Abstract] [Full Text]  
• Marcus, M., Maida, C. A., Coulter, I. D., Freed, J. R., Der-Martirosian, C., Liu, H., Freed, B. A., Guzman-Becerra, N., Andersen, R. M. (2005). A Longitudinal Analysis of Unmet Need for Oral Treatment in a National Sample of Medical HIV Patients. AJPH 95: 73-75 [Abstract] [Full Text]  
• Morales, L. S., Cunningham, W. E., Galvan, F. H., Andersen, R. M., Nakazono, T. T., Shapiro, M. F. (2004). Sociodemographic Differences in Access to Care Among Hispanic Patients Who Are HIV Infected in the United States. AJPH 94: 1119-1121 [Abstract] [Full Text]  
• Poundstone, K. E., Strathdee, S. A., Celentano, D. D. (2004). The Social Epidemiology of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Epidemiol Rev 26: 22-35 [Full Text]  
• Fitzpatrick, L., McCray, E., Smith, D. K. (2004). The Global HIV/AIDS Epidemic and Related Mental Health Issues: The Crisis for Africans and Black Americans. Journal of Black Psychology 30: 11-23 [Abstract]  
• Cargill, V. A., Stone, V. E., Robinson, M. R. (2004). HIV Treatment in African Americans: Challenges and Opportunities. Journal of Black Psychology 30: 24-39 [Abstract]  
• Patterson, E. S, Nguyen, A. D, Halloran, J. P, Asch, S. M (2004). Human Factors Barriers to the Effective Use of Ten HIV Clinical Reminders. J Am Med Inform Assoc 11: 50-59 [Abstract] [Full Text]  
• Mrus, J. M., Yi, M. S., Freedberg, K. A., Wu, A. W., Zackin, R., Gorski, H., Tsevat, J. (2003). Utilities Derived from Visual Analog Scale Scores in Patients with HIV/AIDS. Med Decis Making 23: 414-421 [Abstract]  
• Arenas-Pinto, A, Grant, A D, Edwards, S, Weller, I V D (2003). Lactic acidosis in HIV infected patients: a systematic review of published cases. Sex. Transm. Infect. 79: 340-343 [Abstract] [Full Text]  
• Vitiello, B., Burnam, M. A., Bing, E. G., Beckman, R., Shapiro, M. F. (2003). Use of Psychotropic Medications Among HIV-Infected Patients in the United States. Am. J. Psychiatry 160: 547-554 [Abstract] [Full Text]  
• Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., Louis, T. A. (2003). Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection. NEJM 348: 702-710 [Abstract] [Full Text]  
• King, J. T. Jr., Justice, A. C., Roberts, M. S., Chang, C.-C. H., Fusco, J. S. (2003). Long-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era. Med Decis Making 23: 9-20 [Abstract]  
• Kuehne, F. C., Bethe, U., Freedberg, K., Goldie, S. J. (2002). Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients: Clinical Benefits and Cost-effectiveness. Arch Intern Med 162: 2545-2556 [Abstract] [Full Text]  
• Walkup, J., Satriano, J., Barry, D., Sadler, P., Cournos, F. (2002). HIV Testing Policy and Serious Mental Illness. AJPH 92: 1931-1940 [Abstract] [Full Text]  
• Murphy, D. A., Mitchell, R., Vermund, S. H., Futterman, D. (2002). Factors Associated With HIV Testing Among HIV-Positive and HIV-Negative High-Risk Adolescents: The REACH Study. Pediatrics 110: e36-36 [Abstract] [Full Text]  
• Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., Kilby, M., Wang, L., Whitcomb, J. M., Hellmann, N. S., Richman, D. D. (2002). Antiretroviral-Drug Resistance among Patients Recently Infected with HIV. NEJM 347: 385-394 [Abstract] [Full Text]  
• Buchanan, R. J. (2002). Medicaid Managed Care and Coverage of Prescription Medications. AJPH 92: 1238-1243 [Full Text]  
• Gifford, A. L., Cunningham, W. E., Heslin, K. C., Andersen, R. M., Nakazono, T., Lieu, D. K., Shapiro, M. F., Bozzette, S. A., the HIV Cost and Services Utilization Study Consor, (2002). Participation in Research and Access to Experimental Treatments by HIV-Infected Patients. NEJM 346: 1373-1382 [Abstract] [Full Text]  
• Walensky, R. P., Losina, E., Steger-Craven, K. A., Freedberg, K. A. (2002). Identifying Undiagnosed Human Immunodeficiency Virus: The Yield of Routine, Voluntary Inpatient Testing. Arch Intern Med 162: 887-892 [Abstract] [Full Text]  
• Goldie, S. J., Kaplan, J. E., Losina, E., Weinstein, M. C., Paltiel, A. D., Seage III, G. R., Craven, D. E., Kimmel, A. D., Zhang, H., Cohen, C. J., Freedberg, K. A. (2002). Prophylaxis for Human Immunodeficiency Virus-Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines. Arch Intern Med 162: 921-928 [Abstract] [Full Text]  
• Levine, A. M. (2002). Evaluation and Management of HIV-Infected Women. ANN INTERN MED 136: 228-242 [Abstract] [Full Text]  
• Gange, S J, Barron, Y, Greenblatt, R M, Anastos, K, Minkoff, H, Young, M, Kovacs, A, Cohen, M, Meyer, W A III, Munoz, A (2002). Effectiveness of highly active antiretroviral therapy among HIV-1 infected women. J. Epidemiol. Community Health 56: 153-159 [Abstract] [Full Text]  
• Schackman, B. R., Goldie, S. J., Freedberg, K. A., Losina, E., Brazier, J., Weinstein, M. C. (2002). Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS. Med Decis Making 22: 27-38 [Abstract]  
• Schackman, B. R., Goldie, S. J., Weinstein, M. C., Losina, E., Zhang, H., Freedberg, K. A. (2001). Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults. AJPH 91: 1456-1463 [Abstract] [Full Text]  
• Kahn, J. G., Haile, B., Kates, J., Chang, S. (2001). Health and Federal Budgetary Effects of Increasing Access to Antiretroviral Medications for HIV by Expanding Medicaid. AJPH 91: 1464-1473 [Abstract] [Full Text]  
• Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., Shapiro, M. (2001). Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus-Infected Adults in the United States. Arch Gen Psychiatry 58: 721-728 [Abstract] [Full Text]  
• Wenger, N. S., Kanouse, D. E., Collins, R. L., Liu, H., Schuster, M. A., Gifford, A. L., Bozzette, S. A., Shapiro, M. F. (2001). End-of-Life Discussions and Preferences Among Persons With HIV. JAMA 285: 2880-2887 [Abstract] [Full Text]  
• Weinstein, M. C., Goldie, S. J., Losina, E., Cohen, C. J., Baxter, J. D., Zhang, H., Kimmel, A. D., Freedberg, K. A. (2001). Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness. ANN INTERN MED 134: 440-450 [Abstract] [Full Text]  
• Bozzette, S. A., Joyce, G., McCaffrey, D. F., Leibowitz, A. A., Morton, S. C., Berry, S. H., Rastegar, A., Timberlake, D., Shapiro, M. F., Goldman, D. P., The HIV Cost and Services Utilization Study Consor, (2001). Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy. NEJM 344: 817-823 [Abstract] [Full Text]  
• Freedberg, K. A., Losina, E., Weinstein, M. C., Paltiel, A. D., Cohen, C. J., Seage, G. R., Craven, D. E., Zhang, H., Kimmel, A. D., Goldie, S. J. (2001). The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease. NEJM 344: 824-831 [Abstract] [Full Text]  
• Hader, S. L., Smith, D. K., Moore, J. S., Holmberg, S. D. (2001). HIV Infection in Women in the United States: Status at the Millennium. JAMA 285: 1186-1192 [Abstract] [Full Text]  
• Goldman, D. P., Bhattacharya, J., Leibowitz, A. A., Joyce, G. F., Shapiro, M. F., Bozzette, S. A. (2001). The Impact of State Policy on the Costs of HIV Infection. Med Care Res Rev 58: 31-53 [Abstract]  
• Arno, P. S. (2001). Commentary. Med Care Res Rev 58: 54-59  
• Goldman, D. P., Schoenbaum, M. L., Potosky, A. L., Weeks, J. C., Berry, S. H., Escarce, J. J., Weidmer, B. A., Kilgore, M. L., Wagle, N., Adams, J. L., Figlin, R. A., Lewis, J. H., Cohen, J., Kaplan, R., McCabe, M. (2001). Measuring the Incremental Cost of Clinical Cancer Research. JCO 19: 105-110 [Abstract] [Full Text]  
• Afessa, B., Green, B. (2000). Clinical Course, Prognostic Factors, and Outcome Prediction for HIV Patients in the ICU : The PIP (Pulmonary Complications, ICU Support, and Prognostic Factors in Hospitalized Patients With HIV) Study. Chest 118: 138-145 [Abstract] [Full Text]  
• Clumeck, N. (1999). Choosing the Best Initial Therapy for HIV-1 Infection. NEJM 341: 1925-1926 [Full Text]  
• Freedberg, K. A., Samet, J. H. (1999). Think HIV: Why Physicians Should Lower Their Threshold for HIV Testing. Arch Intern Med 159: 1994-2000 [Full Text]  
• Bartlett, J. G. (1999). Update in Infectious Diseases. ANN INTERN MED 131: 273-280 [Full Text]  
• Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., Athey, L. A., Keesey, J. W., Goldman, D. P., Berry, S. H., Bozzette, S. A., Additional Authors From the HCSUS Consortium, (1999). Variations in the Care of HIV-Infected Adults in the United States: Results From the HIV Cost and Services Utilization Study. JAMA 281: 2305-2315 [Abstract] [Full Text]  
• Horowitz, H. W., Wormser, G. P., El-Sadr, W. (1999). Atovaquone Compared with Dapsone to Prevent Pneumocystis carinii Pneumonia. NEJM 340: 1512-1513 [Full Text]  
• (1999). HIV Care Less Expensive Than Believed. JWatch Infect. Diseases 1999: 10-10 [Full Text]  
• Steinbrook, R. (1998). Caring for People with Human Immunodeficiency Virus Infection. NEJM 339: 1926-1928 [Full Text]